The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
Backes, James, Anzalone, Deborah, Hilleman, Daniel, Catini, Julia
Published in Lipids in health and disease (22.07.2016)
Published in Lipids in health and disease (22.07.2016)
Get full text
Journal Article
PB2150: CARDIAC AMYLOID REACHING FOR EXTENDED SURVIVAL (CARES) TRIALS: 2 PLACEBO‐CONTROLLED, DOUBLE‐BLIND, RANDOMIZED, PHASE 3 TRIALS ASSESSING CAEL‐101 IN PATIENTS WITH MAYO STAGES IIIA/IIIB AL AMYLOIDOSIS
Wechalekar, Ashutosh, Palladini, Giovanni, Molina, Maria Angelica, Kastritis, Efstathios, Ianus, Juliana, Catini, Julia, Quarta, C Cristina, Liedtke, Michaela
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
S204: SAFETY AND TOLERABILITY OF CAEL‐101, AN ANTI‐AMYLOID MONOCLONAL ANTIBODY, COMBINED WITH ANTI‐PLASMA CELL DYSCRASIA THERAPY IN PATIENTS WITH LIGHT‐CHAIN AMYLOIDOSIS: 18‐MONTH RESULTS OF A PHASE 2 STUDY
Valent, Jason, Liedtke, Michaela, Zonder, Jeffrey, Molina, Maria Angelica, Udata, Chandrasekhar, Ianus, Juliana, Tripptree, John, Catini, Julia, Quarta, C Cristina
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy
Quarta, C Cristina, Fontana, Marianna, Damy, Thibaud, Catini, Julia, Simoneau, Damien, Mercuri, Michele, Garcia-Pavia, Pablo, Maurer, Mathew S, Palladini, Giovanni
Published in Frontiers in cardiovascular medicine (20.12.2022)
Published in Frontiers in cardiovascular medicine (20.12.2022)
Get full text
Journal Article
Abstract 12465: The Diagnostic Pathway for Patients With Light Chain (AL) Amyloidosis: Analysis of a Large US Claims Database
Lyons, Genevieve, Thompson, Jeffrey, Lousada, Isabelle, Maurer, mathew S, Catini, Julia, Manwani, Richa
Published in Circulation (New York, N.Y.) (07.11.2023)
Published in Circulation (New York, N.Y.) (07.11.2023)
Get full text
Journal Article
Safety and Tolerability of Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia Therapy in Patients with Light-Chain Amyloidosis: 24-Month Results of a Phase 2 Study
Valent, Jason, Liedtke, Michaela, Zonder, Jeffrey A., Manwani, Richa, Udata, Chandrasekhar, Ianus, Juliana, Tripptree, John, Catini, Julia, Quarta, Candida Cristina
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Enrolling patients in Cardiac Amyloid Reaching for Extended Survival (CARES) trials: Two placebo-controlled, double-blind, randomized, international phase 3 trials assessing CAEL-101 in patients with Mayo stage IIIa or stage IIIb AL amyloidosis
Liedtke, Michaela, Palladini, Giovanni, Molina, Maria Angelica, Kastritis, Efstathios, Ianus, Juliana, Catini, Julia, Quarta, Candida Cristina, Wechalekar, Ashutosh D.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
1-Year Results from a Phase 2 Study to Determine Safety and Tolerability of Treating Patients with Light-Chain (AL) Amyloidosis with Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia
Valent, Jason, Liedtke, Michaela, Zonder, Jeffrey A., Tulchinskiy, Mark, Udata, Chandrasekhar, Ramirez, Girly, Szymaniak, Kate, Catini, Julia, Quarta, Candida Cristina
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Safety And Tolerability Of Cael-101, An Anti-amyloid Monoclonal Antibody, Combined With Anti-plasma Cell Dyscrasia Therapy In Patients With Light-chain Amyloidosis: 18-month Results Of A Phase 2 Study
Valent, Jason, Liedtke, Michaela, Zonder, Jeffrey, Molina, Maria A., Udata, Chandrasekhar, Ianus, Juliana, Tripptree, John, Catini, Julia, Quarta, C Cristina
Published in Journal of cardiac failure (01.01.2024)
Published in Journal of cardiac failure (01.01.2024)
Get full text
Journal Article
Evaluation of the Path to Diagnosis and Time to Treatment in Patients with Light-Chain Amyloidosis Using the Komodo Claims Database
Catini, Julia, Doan, Quan, Evans, Jennifer, Rava, Andrew, Defay, Thomas, Del Angel, Guillermo, Teynor, Megan, Quarta, Candida Cristina, Maurer, Mathew S., Lousada, Isabelle
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
EVALUATION OF THE PATTERNS LEADING TO DIAGNOSIS IN PATIENTS WITH AMYLOID LIGHT-CHAIN AMYLOIDOSIS USING THE KOMODO DATABASE
Catini, Julia N., Doan, Quan, Evans, Jennifer, Shah, Bonny, Rava, Andrew, thanataveerat, anusorn, Defay, Thomas, del Angel, Guillermo, Teynor, Megan, Quarta, Candida Cristina
Published in Journal of the American College of Cardiology (01.03.2022)
Published in Journal of the American College of Cardiology (01.03.2022)
Get full text
Journal Article
SAFETY AND TOLERABILITY OF CAEL-101, AN ANTI-AMYLOID MONOCLONAL ANTIBODY, IN COMBINATION WITH PLASMA CELL DYSCRASIA THERAPY IN PATIENTS WITH LIGHT-CHAIN AMYLOIDOSIS: RESULTS FROM A PHASE 2 STUDY
Valent, Jason, Liedtke, Michaela, Zonder, Jeffrey, Silowsky, John, Kurman, Michael, Daniel, Eileen, Jobes, Janet, Harnett, Mark, Bhattacharyya, Amit, Quarta, Candida Cristina, Catini, Julia, Raviwong, Jessica, Spector, Michael, Sobolov, Susan
Published in Journal of the American College of Cardiology (01.03.2022)
Published in Journal of the American College of Cardiology (01.03.2022)
Get full text
Journal Article
Statins in Chronic Kidney Disease: When and When Not to Use Them
Vaziri, Nosratola D, Anzalone, Deborah A, Catini, Julia
Published in The Journal of family practice (01.08.2016)
Get full text
Published in The Journal of family practice (01.08.2016)
Journal Article